Clinical Trials Directory

Trials / Completed

CompletedNCT00743054

microRNA Expression in Renal Cell Carcinoma

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.

Detailed description

Due to the lack of specific indicators for the early diagnosis of RCC, the RCC patients often have distant metastasis when diagnosed and their five-year survival rate is much low. Therefore, the biological markers of RCC are needed for early detection, early treatment and improvement of the survival rate of RCC patients. MiRNA and tumor are closely related. MiRNA can control the important cancer-related genes and participate in the tumor cell proliferation, apoptosis, invasion and angiogenesis. In this study, RCC related miRNA and the target genes of related miRNA will be examined,and the relationship between RCC related miRNA and the RCC pathological types, TNM (tumor-nodes-metastasis) stages and prognosis will be analyzed. The purpose of this study is to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.

Conditions

Timeline

Start date
2008-07-01
Primary completion
2009-08-01
Completion
2011-08-01
First posted
2008-08-28
Last updated
2015-05-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00743054. Inclusion in this directory is not an endorsement.

microRNA Expression in Renal Cell Carcinoma (NCT00743054) · Clinical Trials Directory